Weight Loss as an Effective, Noninvasive, Nonpharmacological Obesity Treatment for Patients with Cardiovascular Risks White Paper

By Andrea M. Pampaloni, Ph.D.

Cardiovascular disease (CVD) is the leading cause of mortality worldwide, and in the United States someone dies every 36 seconds from the disease. Despite advanced knowledge and its risk factors — and having the medical and technological treatments to help prevent it — incidents of heart failure have been on the rise since 2012 after a 30 year decline. The key factors contributing to this reversal? Obesity and diabetes.

Both epidemics themselves, obesity and diabetes, are closely linked and collectively responsible for about a million deaths each year. Because both are significant cardiometabolic risk factors, an obesity diagnosis and a candid discussion of weight loss and maintenance strategies are critical.

Download the entire White Paper Free --->

First Name:

Last Name:

Email Address:

Country:

State:

Specialty:

Sync to Marketo:

Sync to Marketo (A):

Person Source:

Last Touch Campaign:

utm_id:

utm_source:

Marketing Medium:

Company Name:

Check if currently practicing weight loss:

Job Title:

Phone Number:

Best Form of Contact:

Industry:

Address:

Join the conversation!

Complimentary

White Paper

___

Weight Loss as an Effective, Noninvasive, Nonpharmacological Obesity Treatment for Patients with Cardiovascular Risks